Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High Risk Non-Hodgkin's Lymphoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00569309
What this trial is testing

Immune Reconstitution After Autologous Hematopoietic Stem Cell Transpl for High-Risk Lymphoma

Who this might be right for
LymphomaMultiple Myeloma and Plasma Cell NeoplasmSmall Intestine Cancer
Ohio State University Comprehensive Cancer Center 30
Testing effectiveness (Phase 2)WithdrawnNCT04220008
What this trial is testing

Vorinostat and Combination Chemotherapy Before Donor Stem Cell Transplantation for the Treatment of Relapsed Aggressive B-cell or T-cell Non-Hodgkin Lymphoma

Who this might be right for
Recurrent Aggressive Non-Hodgkin LymphomaRecurrent B-Cell Non-Hodgkin LymphomaRecurrent Burkitt Lymphoma+4 more
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)WithdrawnNCT02961816
What this trial is testing

Panobinostat Combined With High-Dose Gemcitabine/Busulfan/Melphalan With Autologous Stem Cell Transplant for Patients With Refractory/Relapsed Lymphoma

Who this might be right for
Lymphoma
M.D. Anderson Cancer Center
Not applicableStudy completedNCT03042585
What this trial is testing

Autologous Transplant Using Dose-Escalated Total Body Irradiation & Cyclophosphamide & Palifermin for NHL

Who this might be right for
Relapsed Non Hodgkin LymphomaRefractory Non-Hodgkin Lymphoma
Loyola University 17
Early research (Phase 1)Ended earlyNCT02914938
What this trial is testing

ME-401 in Subjects With CLL/SLL, FL, and B-cell Non Hodgkin's Lymphoma

Who this might be right for
Chronic Lymphocytic Leukemia (CLL)Small Lymphocytic Lymphoma (SLL)Follicular Lymphoma (FL)+4 more
MEI Pharma, Inc. 97
Not applicableStudy completedNCT00031668
What this trial is testing

Radiation Therapy in Relapsed or Refractory Non-Hodgkin's Lymphoma Who Have Undergone Stem Cell Transplantation

Who this might be right for
Lymphoma
NCIC Clinical Trials Group 6
Large-scale testing (Phase 3)Study completedNCT01358747
What this trial is testing

Study of a Treatment Driven by Early PET Response to a Treatment Not Monitored by Early PET in Patients With AA Stage 3-4 or 2B HL

Who this might be right for
Hodgkin's Lymphoma
Centre Hospitalier Universitaire Dijon
Testing effectiveness (Phase 2)Study completedNCT01760655
What this trial is testing

Reduced-Intensity Conditioning Before Donor Stem Cell Transplant in With High-Risk Hematologic Malignancies

Who this might be right for
Acute Myeloid Leukemia With FLT3/ITD MutationAcute Myeloid Leukemia With Gene MutationsAcute Myeloid Leukemia With Inv(3) (q21.3;q26.2); GATA2, MECOM+18 more
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 62
Testing effectiveness (Phase 2)Study completedNCT00004132
What this trial is testing

Growth Factor to Prevent Oral Mucositis in Patients With Hematologic Cancer

Who this might be right for
Drug/Agent Toxicity by Tissue/OrganLeukemiaLymphoma+3 more
Jonsson Comprehensive Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT06536049
What this trial is testing

Epcoritamab Plus Ibrutinib for the Treatment of Relapsed or Refractory Aggressive B-Cell Non-Hodgkin Lymphoma

Who this might be right for
Recurrent Diffuse Large B-Cell LymphomaRecurrent Grade 3b Follicular LymphomaRecurrent High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements+11 more
Yazeed Sawalha 38
Large-scale testing (Phase 3)UnknownNCT00002989
What this trial is testing

Combination Chemotherapy With or Without Idarubicin and Peripheral Stem Cell Transplantation in Treating Patients With Leukemia or Myelodysplastic Syndrome

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more
European Organisation for Research and Treatment of Cancer - EORTC 207
Large-scale testing (Phase 3)Study completedNCT01516580
What this trial is testing

Intergroup Randomized Trial for Children or Adolescents With B-Cell Non Hodgkin Lymphoma or B-Acute Leukemia: Rituximab Evaluation in High Risk Patients

Who this might be right for
B-cell Non Hodgkin LymphomaMature B-cell Leukemia Burkitt-type
Gustave Roussy, Cancer Campus, Grand Paris 482
Large-scale testing (Phase 3)UnknownNCT00028717
What this trial is testing

Combination Chemotherapy Plus Filgrastim With or Without Rituximab in Treating Older Patients With Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Commissie Voor Klinisch Toegepast Onderzoek 400
Post-approval studies (Phase 4)UnknownNCT00797810
What this trial is testing

Intensification Therapy of Mature B-ALL, Burkitt and Burkitt Like and Other High Grade Non-Hodgkin's Lymphoma in Adults

Who this might be right for
Acute Lymphoblastic LeukemiaNon-Hodgkin's Lymphoma
University of Bologna 25
Large-scale testing (Phase 3)Study completedNCT01026220
What this trial is testing

Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin Lymphoma

Who this might be right for
Childhood Nodular Lymphocyte Predominant Hodgkin LymphomaStage III Childhood Hodgkin LymphomaStage IV Childhood Hodgkin Lymphoma
Children's Oncology Group 166
Not applicableEnded earlyNCT03154710
What this trial is testing

Relevance of a Web-mediated Follow up in Patients Having a Lymphoma With a High Risk of Relapse in Complete or Partial Response

Who this might be right for
Lymphoma, T-CellLymphoma, Large B-Cell, DiffuseLymphoma, Hodgkin
Weprom 52
Testing effectiveness (Phase 2)Ended earlyNCT00250861
What this trial is testing

Trial of Outpatient Immunotherapy With Rituximab and Aldesleukin (IL-2) vs. Rituximab Alone for Non-Hodgkin's Lymphoma

Who this might be right for
Non-Hodgkin's Lymphoma
US Oncology Research 110
Early research (Phase 1)Not Yet RecruitingNCT07649304
What this trial is testing

AMC 120, Glofitamab Plus Chemoimmunotherapy in Newly Diagnosed HIV-Associated Large B-Cell Lymphoma (The "Glofit-RCHOP Study")

Who this might be right for
AIDS-Related Diffuse Large B-cell LymphomaDiffuse Large B-Cell Lymphoma, Not Otherwise SpecifiedHigh Grade B-Cell Lymphoma With MYC and BCL2 Rearrangements+6 more
National Cancer Institute (NCI) 15
Testing effectiveness (Phase 2)Looking for participantsNCT06365671
What this trial is testing

CAR-T Following ASCT for Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (R/R B-NHL) With High-Risk Prognostic Factors

Who this might be right for
B-cell Non Hodgkin Lymphoma
Ruijin Hospital 16
Testing effectiveness (Phase 2)Study completedNCT00066248
What this trial is testing

Cyproheptadine and Megestrol in Preventing Weight Loss in Children With Cachexia Caused By Cancer or Cancer Treatment

Who this might be right for
Brain TumorCentral Nervous System TumorsCachexia+5 more
University of South Florida 70
Next Page